Dupont Capital Management Corp Myriad Genetics Inc Transaction History

Dupont Capital Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$24.13 - $32.63 $262,630 - $355,144	-10,884 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$29.97 - $36.66 $355,264 - $434,567	-11,854 Reduced 52.13%	10,884 $351,000
Q1 2021 Apr 29, 2021	BUY	$19.92 - $31.6 $452,940 - $718,520	22,738 New	22,738 $692,000
Q3 2019 Oct 28, 2019	SELL	$22.08 - $47.08 $571,099 - $1.22 Million	-25,865 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$27.23 - $45.56 $295,799 - $494,918	10,863 Added 72.41%	25,865 $752,000
Q2 2018 Jul 30, 2018	BUY	$27.75 - $40.17 $149,739 - $216,757	5,396 Added 56.17%	15,002 $561,000
Q1 2018 May 02, 2018	SELL	$28.83 - $41.01 $659,457 - $938,062	-22,874 Reduced 70.42%	9,606 $284,000
Q4 2017 Jan 31, 2018	SELL	$28.45 - $37.14 $401,031 - $523,525	-14,096 Reduced 30.26%	32,480 $1.12 Million
Q3 2017 Oct 31, 2017	BUY	$24.01 - $36.2 $1.12 Million - $1.69 Million	46,576	46,576 $1.69 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.